LinkedIn
      Join now Sign in
      Daniel Fujiwara, PhD (藤原ダニエル)

      Daniel Fujiwara, PhD (藤原ダニエル)

      CEO at Simetrica-Jacobs. Visiting Fellow at London School of Economics and Political Science

      2mo
      • Report this post

      *Covid policy making* In May 2020 I was invited on 2 occasions to meet with senior Government officials to discuss the pros and cons of lockdown measures in the UK. As a Cost-Benefit Analysis (CBA) and policy evaluation expert (who has assessed hundreds of policies for the UK Government) I offered my ongoing advice and input pro bono to the Government, but I never heard back from them. The Government has since then been asked at least 17 times by MPs to conduct a full CBA of #covidー19 policies, but to my understanding this has not happened. CBA measures the benefits and costs (risks) of a policy for people’s quality of life and is used in all major policy decisions in the UK as mandated by the HM Treasury Green Book. Broadly speaking CBA tells us that we should carry on with something up to the point where the benefits of doing so no longer exceed the costs. When we assess costs we must include the opportunity costs of an action, which are the things we forego as society by expending resources on one particular area. Basically, every $ we spend on health and Covid is a $ we cannot spend on crime, the environment or education and this is a loss to society. Lockdowns should have stopped at the point where an additional day of #lockdown causes more damage to our society than it benefits us, and #vaccinations should stop at the point where the costs from vaccinating one more person in the UK exceed the benefits of vaccinating. My analysis of the impacts of lockdown last year suggests that we have gone well beyond this threshold for lockdowns and I suspect we are close to it now for vaccines and this is important as society now starts to consider vaccinating children. Governments have generally taken a very narrow view of the data on Covid when developing policy, focussing on infection and deaths rates and numbers vaccinated but ignoring the costs of our actions and how our resources could have been used elsewhere to potentially greater effect. It has led to one of the greatest oversights in policy making I have ever seen. This excellent article by Martin Kulldorff also discusses some of these issues and is well worth a read.   https://lnkd.in/dTxsWAY

      The ill-advised push to vaccinate the young

      The ill-advised push to vaccinate the young

      thehill.com

      60 4 Comments
      Like Comment
      Richard Dubourg
      Richard Dubourg
      For me, this totally misses the dynamic, potentially exponential nature of COVID infection. If there are extra costs associated with a COVID-reduction policy like lockdown, in a dynamic setting that does not necessarily mean that we should have 'less policy' or 'less lockdown'. We are not talking about a simple MC-MB cross diagram, where if the MB curve goes down, the optimal level of lockdown just goes down too. It is just as likely, if not more so, that additional costs mean the policy should be more intense, stricter, to ensure the policy objective is achieved more quickly and the total and additional costs associated with the policy are minimised over time. The irony is that, by worrying (perfectly reasonably, of course) about the 'external' costs of anti-COVID policies, politicians - and some academics - have prevaricated over policy and made the total outcome - COVID and non-COVID - much worse than it needed to be. My sense is that these people have tended to adopt a naive view of COVID policy and its cost-benefit analysis, rather than one that recognises the constraints and feedback loops in the system.
      Sign in to like this comment
      Sign in to reply to this comment
      3 Likes
      2mo
      • Report this comment
      Gary Yeritsian
      Gary Yeritsian
      Thank you for posting. The absence of CBAs in the UK, US, etc., is a real scandal, especially in light of the abandonment of long established pandemic mitigation guidelines.
      Sign in to like this comment
      Sign in to reply to this comment
      1 Like
      2mo
      • Report this comment

      To view or add a comment, sign in To view or add a comment, sign in

      Daniel Fujiwara, PhD (藤原ダニエル)

      2,114 followers

      • 196 Posts
      • 5 Articles
      View Profile Follow

      More from this author

      • Simetrica is hiring Econometricians and Senior Econometricians

        Daniel Fujiwara, PhD (藤原ダニエル) 3y
      • Simetrica is hiring!

        Daniel Fujiwara, PhD (藤原ダニエル) 4y
      • New job opportunities at Simetrica

        Daniel Fujiwara, PhD (藤原ダニエル) 5y
      • LinkedIn © 2021
      • About
      • Accessibility
      • User Agreement
      • Privacy Policy
      • Cookie Policy
      • Copyright Policy
      • Brand Policy
      • Guest Controls
      • Community Guidelines